Related references
Note: Only part of the references are listed.The FDA's Generic-Drug Approval Process: Similarities to and Differences From Brand-Name Drugs
Costas H. Kefalas et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Failure of copy Imatib (CIPLA, India) to maintain hematologic and cytogenetic responses in chronic myeloid leukemia in chronic phase
Mervat Mattar
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Hematologic Relapse after 2 Years on a Non-Authorized Copy Version of Imatinib in a Patient with Chronic Myeloid Leukemia in Chronic Phase: A Case Report
Zoubir Chouffai
CASE REPORTS IN ONCOLOGY (2010)
Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet
Michele Baccarani et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
F. J. Giles et al.
LEUKEMIA (2009)
Share Paper
